Jing Guo

发表

A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present)

Ke Ding, Jing Guo, Zhen Zhang, 2020, Expert opinion on therapeutic patents.

Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells.

J. Smaill, Liang Chen, A. Patterson, 2022, Journal of medicinal chemistry.

New techniques and strategies in drug discovery

Guan Wang, Zhen Zhang, Jing Guo, 2020, Chinese Chemical Letters.

Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors.

Yong Xu, Xiaoyun Lu, Zheng-chao Tu, 2020, European journal of medicinal chemistry.

Design, Synthesis, and Biological Evaluation of 5-Formyl-pyrrolo[3,2-b]pyridine-3-carboxamides as New Selective, Potent, and Reversible-Covalent FGFR4 Inhibitors.

J. Smaill, Zheng-chao Tu, A. Patterson, 2022, Journal of medicinal chemistry.

Discovery of AXL Degraders with Improved Potencies in Triple-Negative Breast Cancer (TNBC) Cells.

Yongxing Wang, Zheng-chao Tu, Zhen Wang, 2023, Journal of medicinal chemistry.

Anti-arthritic activities of ethanol extracts of Circaea mollis Sieb. & Zucc. (whole plant) in rodents.

Jiachun Chen, Qun Zhou, Yanhong Yu, 2018, Journal of ethnopharmacology.

GZD824 overcomes FGFR1‐V561F/M mutant resistance in vitro and in vivo

Zheng-chao Tu, K. Ding, Zhang Zhang, 2021, Cancer medicine.

Discovery of novel TrkA allosteric inhibitors: Structure-based virtual screening, biological evaluation and preliminary SAR studies

S. Xiang, Xiaoyun Lu, Ke Ding, 2021, European Journal of Medicinal Chemistry.

Design, Synthesis, and Evaluation of (R)-8-((Tetrahydrofuran-2-yl)methyl)pyrido[2,3-d]pyrimidin-7-ones as Novel Selective ACK1 Inhibitors to Combat Acquired Resistance to the Third-Generation EGFR Inhibitor.

Lin-jiang Tong, Hua Xie, Qian Li, 2023, Journal of medicinal chemistry.